What does ozanimod mainly treat?

Ozamod (ozanimod) is indicated for the treatment of adult patients with relapsing-remitting multiple sclerosis (RRMS) who have active disease as defined by clinical or imaging features; is also indicated for the treatment of adults with moderately to severely active ulcerative colitis (UC) who have an inadequate response, loss of response, or are intolerant to either conventional therapies or biologics. Itis an anti-inflammatory drug that changes the immune system, but not in the same way as biologics. It affects the immune system by blocking the ability of lymphocytes (white blood cells) to escape from lymph nodes into the blood, intestines, central nervous system, and inflammatory tissues.